1. Home
  2. CPF vs HELP Comparison

CPF vs HELP Comparison

Compare CPF & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Pacific Financial Corp New

CPF

Central Pacific Financial Corp New

HOLD

Current Price

$37.87

Market Cap

916.6M

Sector

Finance

ML Signal

HOLD

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

HOLD

Current Price

$10.47

Market Cap

862.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPF
HELP
Founded
1954
2019
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
916.6M
862.2M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
CPF
HELP
Price
$37.87
$10.47
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
★ $41.75
$41.40
AVG Volume (30 Days)
125.1K
★ 1.3M
Earning Date
10-28-2026
11-12-2026
Dividend Yield
★ 3.18%
N/A
EPS Growth
★ 45.18
N/A
EPS
★ 1.58
N/A
Revenue
★ $51,817,000.00
N/A
Revenue This Year
$4.16
N/A
Revenue Next Year
$3.45
N/A
P/E Ratio
$23.92
★ N/A
Revenue Growth
★ 33.81
N/A
52 Week Low
$28.10
$3.76
52 Week High
$40.99
$15.15

Technical Indicators

Market Signals
Indicator
CPF
HELP
Relative Strength Index (RSI) 63.46 43.27
Support Level $36.91 $9.97
Resistance Level $38.34 $14.75
Average True Range (ATR) 0.65 0.93
MACD 0.29 -0.05
Stochastic Oscillator 90.20 21.68

Price Performance

Historical Comparison
CPF
HELP

About CPF Central Pacific Financial Corp New

Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services. It operates in single segment which is Banking operations.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: